logo

For the Inventor, By the Inventor

Seoul, South Korea

Seong Jun Yoon

USPTO Granted Patents = 47 


 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:

goldMedal46 out of 68 
 
Intron Biotechnology, Inc.
 patents
silverMedal1 out of 1 
 
Intron Blotechnology, Inc.
 patent

Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antibacterial Proteins
Bacteriophage Therapy
Pathogenic Inhibition
Gram Negative Infections
RNA Therapeutics
Vibrio Parahaemolyticus
Heme Iron Preparation
Staphylococcal Infections
Bacteriolytic Activity
Lysin Proteins
Enterotoxigenic Bacteria
Clostridium Perfringens
47 patents (USPTO):Explore Patents
1. 12358953 - Antibacterial protein having lytic activity togenus and method for preparing the same (2025-07-15),
2. 12280081 - Compositions and methods for inhibiting the proliferation of enterotoxigenic (2025-04-21),
3. 12274721 - Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis (2025-04-14),
4. 12263196 - Compositions and methods for inhibiting the proliferation of enterotoxigenic (2025-04-01),
5. 12114664 - bacteriophage STP-2 and use thereof for inhibiting proliferation of (2024-10-15),
6. 11970700 - Genetic element E3 for enhanced intracellular expression of target protein encoded in RNA therapeutics (2024-04-30),
7. 11844818 - bacteriophage Aer-HYP-3 and use thereof for inhibiting growth ofbacteria (2023-12-19),
8. 11701398 - Compositions and methods for inhibiting the proliferation of pathogenic (2023-07-18),
9. 11679138 - Vibrio parahaemolyticus bacteriophage Vib-PAP-7 and use of same for inhibiting vibrio parahaemolyticus bacteria proliferation (2023-06-20),
10. 11679137 - bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation ofbacteria (2023-06-20),
11. 11596659 - Compositions and methods for inhibiting the proliferation of pathogenic (2023-03-07),
12. 11583565 - Compositions and methods for inhibiting the proliferation of pathogenic (2023-02-21),
13. 11548917 - Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same (2023-01-10),
14. 11529406 - bacteriophage Clo-PEP-2 and use for inhibitingproliferation of same (2022-12-20),
15. 11497216 - bacteriophage pse-AEP-4 and use thereof for inhibiting proliferation of (2022-11-15),

Title: The Innovative Contributions of Seong Jun Yoon in Biotechnology

Introduction: Seong Jun Yoon, a prominent inventor based in Seoul, South Korea, has made significant advancements in the field of biotechnology, with an impressive portfolio of 43 patents. His pioneering work focuses on the development of novel solutions for health and disease management, showcasing his commitment to enhancing the well-being of individuals through scientific innovation.

Latest Patents: Among his latest patents are two notable inventions. The first patent features a bacteriophage, identified as STP-2 (Accession number: KCTC 12853BP), which has shown great promise in inhibiting the proliferation of harmful bacteria. This bacteriophage is naturally isolated and characterized by its unique genome represented by SEQ ID NO:1. The invention emphasizes a method for preventing and treating diseases by utilizing bacteriophage STP-2 as an active ingredient.

In addition, Seong Jun Yoon has developed a genetic element known as E3, designed to enhance the intracellular expression of target proteins encoded in RNA therapeutics. This innovation is particularly relevant for mRNA vaccines and RNA medicines. The patent details the RNA molecule imbued with the genetic element E3, the specific plasmid used for synthesizing this RNA molecule, and the methods involved in its synthesis and application in RNA therapeutics.

Career Highlights: Seong Jun Yoon has had a noteworthy career, contributing his expertise to esteemed organizations such as Intron Biotechnology, Inc. and Intron Biotechnology, Inc., underscoring his significant role in advancing biotechnological research and development.

Collaborations: Throughout his career, Yoon has collaborated with talented individuals in his field, including his coworkers Sang Hyeon Kang and Soo Youn Jun. These partnerships have fostered a dynamic exchange of ideas and innovations that have further propelled his contributions to biotechnology.

Conclusion: Seong Jun Yoon exemplifies the spirit of innovation in the field of biotechnology, as demonstrated by his numerous patents and collaborative work. His inventions, particularly in bacteriophage technology and RNA therapeutics, highlight the potential for scientific advancements to address pressing health challenges. His ongoing contributions continue to inspire and shape the future of biotechnology, positively impacting health solutions worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…